1. Home
  2. CASI vs GIGM Comparison

CASI vs GIGM Comparison

Compare CASI & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • GIGM
  • Stock Information
  • Founded
  • CASI 1991
  • GIGM 1998
  • Country
  • CASI China
  • GIGM Taiwan
  • Employees
  • CASI N/A
  • GIGM N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • GIGM Computer Software: Programming Data Processing
  • Sector
  • CASI Health Care
  • GIGM Technology
  • Exchange
  • CASI Nasdaq
  • GIGM Nasdaq
  • Market Cap
  • CASI 20.5M
  • GIGM 17.9M
  • IPO Year
  • CASI 1996
  • GIGM 2000
  • Fundamental
  • Price
  • CASI $1.40
  • GIGM $1.43
  • Analyst Decision
  • CASI Strong Buy
  • GIGM
  • Analyst Count
  • CASI 1
  • GIGM 0
  • Target Price
  • CASI $4.00
  • GIGM N/A
  • AVG Volume (30 Days)
  • CASI 313.5K
  • GIGM 14.9K
  • Earning Date
  • CASI 08-15-2025
  • GIGM 07-30-2025
  • Dividend Yield
  • CASI N/A
  • GIGM N/A
  • EPS Growth
  • CASI N/A
  • GIGM N/A
  • EPS
  • CASI N/A
  • GIGM N/A
  • Revenue
  • CASI $31,368,000.00
  • GIGM $3,103,000.00
  • Revenue This Year
  • CASI N/A
  • GIGM N/A
  • Revenue Next Year
  • CASI N/A
  • GIGM N/A
  • P/E Ratio
  • CASI N/A
  • GIGM N/A
  • Revenue Growth
  • CASI 8.39
  • GIGM N/A
  • 52 Week Low
  • CASI $1.09
  • GIGM $1.26
  • 52 Week High
  • CASI $7.67
  • GIGM $1.80
  • Technical
  • Relative Strength Index (RSI)
  • CASI 44.81
  • GIGM 48.89
  • Support Level
  • CASI $1.23
  • GIGM $1.41
  • Resistance Level
  • CASI $1.50
  • GIGM $1.52
  • Average True Range (ATR)
  • CASI 0.12
  • GIGM 0.04
  • MACD
  • CASI 0.03
  • GIGM 0.01
  • Stochastic Oscillator
  • CASI 78.05
  • GIGM 40.60

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About GIGM GigaMedia Limited

GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.

Share on Social Networks: